dividends
RP
NASDAQ · RPRX
Royalty Pharma plc
Healthcare · Biotechnology
$56.66
Down-$0.50 (-0.87%)
Updated Oct 6, 2026, 3:41 AM
SID Score
6.9/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 16.85B
- P/E ratio
- 16.44
- Dividend yield
- 1.55%
- 52-week range
- $35.23 – $64.38
- Volume
- 3.96M
- Avg. volume
- 4.22M
Price performance · RPRX
RPRX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
RPRX closed at $56.66 after 20 trading sessions, down 6.49% for the selected period.
- Last close
- $56.66
- Period change
- -6.49%
- Period low
- $56.66
- Period high
- $60.59
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $57.10 | $57.25 | $56.005 | $56.66 | 3.96M |
| Oct 2, 2026 | $57.635 | $57.91 | $56.96 | $57.16 | 2.23M |
| Oct 1, 2026 | $58.36 | $58.40 | $57.22 | $57.63 | 3.25M |
| Sep 30, 2026 | $58.07 | $58.64 | $57.70 | $58.36 | 3.65M |
| Sep 29, 2026 | $58.19 | $58.475 | $57.51 | $58.22 | 2.89M |
| Sep 28, 2026 | $57.88 | $58.765 | $57.63 | $58.37 | 1.86M |
| Sep 25, 2026 | $58.50 | $58.50 | $57.68 | $58.21 | 1.87M |
| Sep 24, 2026 | $57.69 | $58.87 | $57.66 | $58.29 | 2.02M |
| Sep 23, 2026 | $58.52 | $59.02 | $57.63 | $57.65 | 2.8M |
| Sep 22, 2026 | $58.27 | $59.03 | $57.855 | $58.52 | 2.69M |
| Sep 21, 2026 | $58.555 | $59.065 | $57.82 | $58.44 | 3.23M |
| Sep 18, 2026 | $58.63 | $58.96 | $57.97 | $58.41 | 7.1M |
| Sep 17, 2026 | $58.81 | $59.18 | $58.46 | $58.93 | 2.06M |
| Sep 16, 2026 | $59.00 | $59.17 | $58.27 | $58.47 | 2.16M |
| Sep 15, 2026 | $59.00 | $59.20 | $57.91 | $58.47 | 2.75M |
| Sep 14, 2026 | $58.66 | $59.55 | $57.75 | $59.05 | 2.97M |
| Sep 11, 2026 | $58.95 | $59.54 | $58.35 | $58.61 | 2.6M |
| Sep 10, 2026 | $60.445 | $60.71 | $58.64 | $58.75 | 3.32M |
| Sep 9, 2026 | $60.60 | $60.80 | $59.31 | $60.59 | 4.34M |
| Sep 8, 2026 | $59.21 | $60.86 | $58.63 | $60.59 | 8.63M |
Latest RPRX news
The latest Smart Investors Daily articles mentioning RPRX.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

